Monash Biotech
May 27th, 2024
This in-depth glossary delves into the world of Intracytoplasmic Sperm Injection (ICSI), providing embryologists with a clear understanding of the essential terminology, procedures, and considerations involved in this advanced fertility technique.
Blastocyst:
A mature embryo (typically 5–6 days post-fertilization) characterized by an inner cell mass (blastocyst inner cell mass, BICM) and a fluid-filled cavity (blastocyst cavity, BC). Blastocyst transfer is a common practice in ICSI cycles.
Blastocyst Culture:
Extending embryo development in vitro for several days beyond cleavage stages to reach the blastocyst stage, potentially improving implantation rates.
Blastocyst Selection:
Choosing the most viable blastocyst for transfer based on its morphology (appearance) and development stage using established grading systems.
Cleavage Stage:
The initial stages of cell division following fertilization, where the zygote undergoes rapid mitotic divisions to form a multicellular embryo (blastomere).
Cryopreservation:
The process of freezing and storing sperm, oocytes, or embryos at ultra-low temperatures for future use in assisted reproductive technologies (ART) cycles.
Embryo:
A fertilized egg that has undergone cell division and begun to develop into a multicellular organism.
Gamete Intrafallopian Transfer (GIFT):
A fertility treatment where oocytes and sperm are placed directly into a fallopian tube, allowing natural fertilization to occur. Not commonly used in conjunction with ICSI.
Mature Metaphase II Oocyte (MII oocyte):
An oocyte in its final stage of meiotic maturation, arrested at metaphase II and ready for fertilization.
Oocyte (Egg):
The female reproductive cell that fuses with a sperm to form a zygote.
Oocyte Retrieval:
The minimally invasive procedure of collecting oocytes from the ovaries, typically guided by transvaginal ultrasound.
Sperm:
The male reproductive cell that fertilizes the oocyte.
Zona Pellucida (ZP):
The transparent glycoprotein shell surrounding the oocyte, playing a crucial role in sperm-egg interaction and preventing polyspermy (fertilization by multiple sperm).
Endometriosis:
A condition where endometrial tissue grows outside the uterus, potentially impacting fertility by altering the endometrial environment.
Hysterosalpingography (HSG):
An X-ray examination to assess the patency and health of the fallopian tubes and uterus. May be performed before ICSI to evaluate potential implantation sites.
Male Factor Infertility:
A condition where sperm quality or quantity hinders natural conception. ICSI is often the recommended treatment option in such cases.
Ovarian Hyperstimulation Syndrome (OHSS):
A complication of ovarian stimulation medications used in IVF cycles, characterized by enlarged ovaries and fluid buildup in the abdomen.
Pelvic Inflammatory Disease (PID):
An infection of the female reproductive organs that can damage fallopian tubes and impact fertility.
Varicocele:
An enlargement of the veins in the scrotum, potentially affecting sperm quality.
Assisted Hatching Technique:
A procedure where the zona pellucida is thinned or weakened using lasers or chemicals to facilitate embryo implantation. May be considered for embryos with a thickened zona pellucida.
Follicle Stimulating Hormone (FSH):
A pituitary hormone that stimulates the development of follicles in the ovaries, often used in controlled ovarian stimulation (COS) protocols to promote multiple mature oocytes for ICSI.
Intracytoplasmic Morphologically Selected Sperm Injection (ICSI-MSI):
A specialized ICSI technique where high magnification and morphological analysis are used to select sperm with normal morphology for injection.
Intracytoplasmic Round Spermatid Injection (ICSI-ROSI):
An advanced technique using immature germ cells (round spermatids) retrieved from the testicles for ICSI in cases of severe male factor infertility.
Intracytoplasmic Sperm Injection (ICSI):
A form of IVF where a single healthy sperm is directly injected into the cytoplasm of the oocyte using micromanipulation techniques, bypassing the natural process of fertilization.
In Vitro Fertilization (IVF):
A broader term encompassing the process of fertilization occurring outside the body. Oocytes are retrieved, fertilized with sperm in a laboratory dish, and viable embryos are transferred back into the uterus.
Luteinizing Hormone (LH):
A pituitary hormone that triggers ovulation (oocyte release) from the ovary.
Ovulation Induction:
Medications or procedures used to stimulate ovulation in women who do not ovulate naturally. Often used in conjunction with ICSI cycles.
Percutaneous Epididymal Sperm Aspiration (PESA):
A surgical procedure to retrieve sperm directly from the epididymis, a coiled structure located above the testes, in cases of blockage preventing sperm from reaching the ejaculate.
Testicular Sperm Aspiration (TESA):
A surgical procedure to extract sperm directly from testicular tissue in cases of severe male factor infertility where sperm are absent from the ejaculate.
Agglutination:
Clumping of sperm cells, potentially hindering their motility and ability to reach the oocyte.
Motility:
The ability of sperm to move effectively, essential for reaching and fertilizing the oocyte. Various motility parameters are assessed during semen analysis.
Oligospermia:
Low sperm count, a potential indicator of male factor infertility.
Oligozoospermia:
Low sperm motility, impacting their ability to reach the oocyte.
Sperm Washing:
A technique used to separate sperm from seminal fluid and other cellular debris before ICSI to improve sperm quality and reduce the risk of introducing harmful substances into the oocyte.
Aneuploidy:
An abnormal number of chromosomes in an embryo, potentially leading to pregnancy complications or miscarriage.
Preimplantation Genetic Diagnosis (PGD):
A diagnostic technique used to analyze embryos for specific genetic conditions before transfer, allowing selection of unaffected embryos for implantation.
Preimplantation Genetic Screening (PGS):
A screening technique used to assess the chromosomal makeup of embryos to identify those with a normal number of chromosomes (euploid), potentially increasing implantation and pregnancy rates.
Acrosome Reaction:
A crucial step where enzymes within the sperm head dissolve the zona pellucida, facilitating sperm-egg fusion. This process can be artificially induced during ICSI.
Microinjection:
The precise injection of a single sperm cell into the cytoplasm of the oocyte using specialized equipment like micromanipulators and injection needles.
Micromanipulation:
The use of specialized instruments under a microscope to handle oocytes, sperm, and embryos during ICSI procedures. This requires a high level of dexterity and technical expertise from the embryologist.
Fertilization Rate:
The percentage of oocytes injected with sperm that successfully undergo fertilization and begin cell division.
Embryo Selection:
Choosing the most viable embryos for transfer based on established criteria, including morphology, cleavage rate, and development stage.
Embryo Culture:
Maintaining embryos in a controlled laboratory environment to support their development until the transfer stage.
Embryo Transfer:
The process of transferring one or more selected embryos back into the woman’s uterus for potential implantation.
ICSI with Testicular Sperm Extraction (TESE-ICSI):
A combined approach using TESE to retrieve sperm and ICSI for fertilization, offering hope for men with severe male factor infertility.
ICSI with Artificial Activation Methods:
Techniques to artificially induce the acrosome reaction in sperm when it fails to occur naturally, potentially improving fertilization rates.
ICSI is a complex and precise procedure demanding a high level of technical expertise and knowledge from embryologists. A thorough understanding of the scientific principles, underlying conditions, and technical procedures is crucial for successful ICSI outcomes.
This glossary provides a comprehensive foundation for embryologists to navigate the world of ICSI and contribute to achieving optimal results for patients seeking fertility treatment.